secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001104659-24-032384
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS terminates EVP General Counsel and SVP Chief Commercial Officer; reorganizes leadership
--------------------------------------------------------------------------------

- Barbara Wood (EVP, GC, Corp Secretary) terminated without cause, effective April 15, 2024.
- Robert Francomano (SVP, Chief Commercial Officer) terminated without cause, effective March 31, 2024.
- Company streamlines leadership, engages commercial consultant for partnerships; Stacy Yeung promoted to VP legal/compliance.
- CEO reaffirms focus on Phase 3 REGAL interim analysis and SLS009 topline data in Q1/Q2 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/0001104659-24-032384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924032384/tm248331d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-032384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer